Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01850082 · ClinicalTrials.gov registry record · NA
Randomized Endo-Vein Graft Prospective
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 1,150
- Enrollment target
NCT01850082: Completed NA study, sponsored by VA Office of Research and Development.
NCT01850082 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 1,150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01850082, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,150 participants
- Enrollment target
Study Summary
Coronary artery bypass grafting (CABG) is the most common major surgical procedure in the United States with over 300,000 cases performed each year. To restore blood flow to the heart, vascular conduits from another part of the body are procured to create a bypass around critically blocked coronary arteries. The left internal thoracic artery is the conduit of choice for CABG due to its superior long-term patency. However, almost all patients referred for CABG require additional grafts to provide complete revascularization. This necessitates the harvest of other vessels, most commonly the saphenous vein which is used almost ubiquitously in contemporary CABG with an average of two vein grafts per CABG procedure. In the last 10 years, Endoscopic Vein Harvesting (EVH) has been recommended as the preferred method over the traditional open harvesting technique (OVH) because it provides a minimally invasive approach. However, more recent investigations indicate potential for reduced long-term bypass graft patency and worse clinical outcomes with EVH. The long term impact of EVH on clinical outcomes has never been investigated on a large scale using a definitive, adequately powered, prospective Randomized Controlled Trial (RCT) with long-term follow-up.
Interventions
- PROCEDURE Vein Harvesting Procedures
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,150 participants |
| Start Date | 2013-09-30 |
| Est. Completion | 2020-10-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01850082
The ClinicalTrials.gov registry entry for NCT01850082 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vein Harvesting Procedures is the first listed.
NCT01850082 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01850082 about?
NCT01850082 is a clinical study titled "Randomized Endo-Vein Graft Prospective". Coronary artery bypass grafting (CABG) is the most common major surgical procedure in the United States with over 300,000 cases performed each year. To restore blood flow to the heart, vascular conduits from another part of the body are procured to create a bypass around critically blocked coronary ...
What is the current status of trial NCT01850082?
This trial is currently completed. It is a NA study. The enrollment target is 1,150 participants. The study started on 2013-09-30. Estimated completion is 2020-10-30.
What interventions are being tested in trial NCT01850082?
The interventions under investigation include: Vein Harvesting Procedures (PROCEDURE).
Who is sponsoring clinical trial NCT01850082?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.